Kouji Okumura
Algemeen Directeur bij NIPPON SHIKIZAI, INC.
Vermogen: 2 M $ op 30-04-2024
Profiel
Kouji Okumura is currently the Chairman & Chief Executive Officer at Nippon Shikizai, Inc. He previously worked as the President at Thepenier Pharma & Cosmetics SAS.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
NIPPON SHIKIZAI, INC.
12.00% | 31-08-2023 | 252 000 ( 12.00% ) | 2 M $ | 30-04-2024 |
Actieve functies van Kouji Okumura
Bedrijven | Functie | Begin |
---|---|---|
NIPPON SHIKIZAI, INC. | Algemeen Directeur | 01-06-2016 |
Eerdere bekende functies van Kouji Okumura
Bedrijven | Functie | Einde |
---|---|---|
Thepenier Pharma & Cosmetics SAS
Thepenier Pharma & Cosmetics SAS Pharmaceuticals: MajorHealth Technology Thepenier Pharma & Cosmetics SAS manufactures liquid and semi-solid products in the framework of full-service contracts. Its products include pasty, liquid, and powder form. The firm also offers services like production & logistics, industrial transposition, cosmetic formulation, and regulation support. Thepenier Pharma & Cosmetics was founded by Roger Thepenier in 1964 and is headquartered in Boulogne Billancourt, France. | President | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NIPPON SHIKIZAI, INC. | Consumer Non-Durables |
Bedrijven in privébezit | 1 |
---|---|
Thepenier Pharma & Cosmetics SAS
Thepenier Pharma & Cosmetics SAS Pharmaceuticals: MajorHealth Technology Thepenier Pharma & Cosmetics SAS manufactures liquid and semi-solid products in the framework of full-service contracts. Its products include pasty, liquid, and powder form. The firm also offers services like production & logistics, industrial transposition, cosmetic formulation, and regulation support. Thepenier Pharma & Cosmetics was founded by Roger Thepenier in 1964 and is headquartered in Boulogne Billancourt, France. | Health Technology |